LASELVA, ONOFRIO
 Distribuzione geografica
Continente #
EU - Europa 977
NA - Nord America 889
AS - Asia 57
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.936
Nazione #
US - Stati Uniti d'America 850
IE - Irlanda 509
IT - Italia 144
SE - Svezia 129
UA - Ucraina 114
CA - Canada 39
FI - Finlandia 28
IN - India 27
DE - Germania 13
GB - Regno Unito 13
CN - Cina 10
FR - Francia 7
BR - Brasile 6
TR - Turchia 6
BE - Belgio 5
IR - Iran 4
DK - Danimarca 3
SG - Singapore 3
CL - Cile 2
EC - Ecuador 2
JP - Giappone 2
NL - Olanda 2
PL - Polonia 2
RO - Romania 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
KR - Corea 1
LU - Lussemburgo 1
OM - Oman 1
PK - Pakistan 1
PT - Portogallo 1
RU - Federazione Russa 1
VA - Santa Sede (Città del Vaticano) 1
Totale 1.936
Città #
Dublin 509
Chandler 241
Ashburn 94
Nyköping 94
Jacksonville 60
Princeton 46
Wilmington 31
Helsinki 27
Pune 23
New York 16
Des Moines 14
Redwood City 13
Toronto 11
Milan 9
San Mateo 9
Bari 8
Santa Marinella 8
Cedar Knolls 7
Los Angeles 7
Rome 7
Torino 7
San Severo 6
Seattle 6
Foggia 5
Houghton 5
Brussels 4
Leawood 4
Catania 3
Chicago 3
Hamilton 3
Kocaeli 3
Nanjing 3
Norwalk 3
Paris 3
Turin 3
Angri 2
Aprilia 2
Ardabil 2
Augusta 2
Barletta 2
Borås 2
Brighton 2
Burnaby 2
Cambridge 2
Caserta 2
Castellammare di Stabia 2
Columbia 2
Delta 2
Derby 2
Fasano 2
Iowa City 2
Krakow 2
Lyngby 2
Padova 2
Quito 2
Rockville 2
Stevenage 2
Surrey 2
São Paulo 2
Tampa 2
Taranto 2
Acquaviva delle Fonti 1
Atlanta 1
Atlantic Mine 1
Baricella 1
Beijing 1
Belmont 1
Billings 1
Bologna 1
Bordeaux 1
Brindisi 1
Brisbane 1
Broomfield 1
Buenos Aires 1
Cedar Rapids 1
Central 1
Changsha 1
Chengdu 1
Chesterfield 1
Conversano 1
Deurne 1
Dhaka 1
Ferrara 1
Frankfurt Am Main 1
Ginosa 1
Greenwich 1
Hackensack 1
Hanover 1
Hebei 1
Hilzingen 1
Huddinge 1
Isernia 1
Islamabad 1
Knoxville 1
Kunming 1
London 1
Luxembourg 1
Madrid 1
Malo 1
Markham 1
Totale 1.386
Nome #
D1152H MUTATION SHOWS A BICARBONATE BUT NOT A CHLORIDE DEFECT IN PRIMARY NASAL EPITHELIAL CELLS 90
Correctors of mutant CFTR enhance subcortical cAMP/PKA signaling via ezrin phosphorylation and cytoskeleton organization 79
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells 78
Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator 53
Anti-infectives enhance ORKAMBI rescue of F508del-CFTR function in human bronchial epithelial cells infected with clinical strains of P. aeruginosa 51
The era of CFTR modulators: improvements made and remaining challenges 51
Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis 50
MODELING CYSTIC FIBROSIS DISEASE AND THERAPIES IN PATIENT DERIVED TISSUES 50
AN ADENOVIRAL VECTOR EXPRESSING CFTR CAN BE USED TO BENCHMARK CFTR MODULATOR RESPONSES IN PATIENT-DERIVED NASAL EPITHELIAL CELLS 50
Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation 49
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system 48
Activity of Lumacaftor is not conserved in zebrafish Cftr bearing the major Cystic Fibrosis-causing mutation 48
Photochemically Activated Notch Signaling Hydrogel Preferentially Differentiates Human Derived Hepatoblasts to Cholangiocytes 47
ASSESSING THE NEED FOR CORRECTOR COMBINATIONS FOR MISFOLDED CF VARIANTS OTHER THAN F508DEL 46
MODULATION OF CFTR BY ITS PHOSPHORYLATION AND INTERACTION WITH SMALL MOLECULES 46
Human Amniotic Mesenchymal Stem Cells and Fibroblasts Accelerate Wound Repair of Cystic Fibrosis Epithelium 42
Allele-specific prevention of nonsense-mediated decay in cystic fibrosis using homology-independent genome editing 42
TRIMETHYLANGELICIN (TMA) BINDS DIRECTLY TO PURIFIED WILD-TYPE CFTR 42
HUMAN IPSCS AND NASAL CELL MODELS FOR CFTR THERATYPING 42
Rescue of multiple class II CFTR mutations by elexacaftor+ tezacaftor+ivacaftor mediated in part by the dual activities of Elexacaftor as both corrector and potentiator 42
Cholesterol interaction directly enhances intrinsic activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 41
Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers 40
TOWARDS THE DETERMINATION OF THE BINDING SITE OF IVACAFTOR ON CFTR THROUGH USE OF PHOTOAFFINITY LABELING PROBES 40
Comprehensive mapping of Cystic Fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site 39
Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series 38
Characterization of anti-proliferative and anti-oxidant effects of nano-sized vesicles from Brassica oleracea L. (Broccoli) 37
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 37
Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers 37
Correctors of the major Cystic Fibrosis mutant interact through membrane spanning domains 37
STUDYING THE DISTINCT SENSITIVITIES OF CFTR MODULATORS USING ZEBRAFISH-CFTR 37
A helper-dependent adenoviral vector rescues CFTR to wild type functional levels in CF epithelial cells harbouring class I mutations 37
The CFTR mutation c.3452G>C (D1152H) confers an anion selectivity defect in primary airway tissue that can be rescued by Ivacaftor 36
Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants 35
A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein 33
Human Amniotic Mesenchymal Stem Cells and Fibroblasts AccelerateWound Repair of Cystic Fibrosis Epithelium 32
Stage-Specific Generation of Human Pluripotent Stem Cell Derived Lung Models to Measure CFTR Function 30
Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action 30
ORKAMBI/amplifier co-therapy rescues a rare CFTR mutation in gene-edited cells and patient tissue 30
Trimethylangelicin promotes the functional rescue of F508del CFTR in CF airway cells 30
The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis 30
Small-molecule drugs for cystic fibrosis: Where are we now? 30
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 26
Orkambi mediated rescue of mucociliary clearance in CF primary respiratory cultures is enhanced by arginine uptake, arginase inhibition and promotion of nitric oxide signalling to the CFTR channel 26
A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients 26
Induced pluripotent stem cells for cystic fibrosis 26
The investigational Cystic Fibrosis drug Trimethylangelicin directly modulates CFTR by stabilizing the first membrane-spanning domain 25
IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression 24
Molecular mechanism of action of Trimethylangelicin derivatives as CFTR modulators 23
Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators 23
Generation of functional ciliated cholangiocytes from human pluripotent stem cells 23
The Oncogenic Theory of Preeclampsia: Is Amniotic Mesenchymal Stem Cells-Derived PLAC1 Involved? 21
Phenotyping rare cftr mutations reveal functional expression defects restored by trikaftatm 21
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 21
High-throughput functional analysis of CFTR and other apically localized proteins in iPSC-derived human intestinal organoids 19
One-Step Formation of Protein-Based Tubular Structures for Functional Devices and Tissues 15
Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium 13
Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis 8
Totale 2.122
Categoria #
all - tutte 15.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202010 3 1 0 0 1 0 2 0 1 0 1 1
2020/2021376 55 10 25 3 28 5 33 60 68 38 3 48
2021/2022257 15 12 16 3 22 10 16 26 30 32 7 68
2022/20231.222 101 37 28 83 63 121 27 87 600 22 24 29
2023/2024234 31 16 9 8 13 77 16 57 0 7 0 0
Totale 2.122